Demand for Antipsychotic Drugs in UK
Demand for Antipsychotic Drugs in UK Size and Share Forecast Outlook 2025 to 2035
Demand for antipsychotic drugs in UK is projected to grow from USD 1.0 billion in 2025 to USD 1.7 billion by 2035, at a CAGR of 5.7%. Schizophrenia will dominate with a 42.1% market share, while aripiprazole will lead the drug type segment with a 24.7% share.
- FACT12629MR
- 15 Dec 2025
- Healthcare
- 170 Pages
- 6 Tables
- 21 Figures
Table of Content
- Executive Summary
- UK Market Outlook
- Demand to side Trends
- Supply to side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Market Background
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Trends
- Scenario Forecast
- Demand in Optimistic Scenario
- Demand in Likely Scenario
- Demand in Conservative Scenario
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter’s Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Market Dynamics
- UK Market Analysis 2020 to 2024 and Forecast, 2025 to 2035
- Historical Market Size Value (USD Million) Analysis, 2020 to 2024
- Current and Future Market Size Value (USD Million) Projections, 2025 to 2035
- Y to o to Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- UK Market Pricing Analysis 2020 to 2024 and Forecast 2025 to 2035
- UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Disease Indication
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Disease Indication, 2020 to 2024
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Disease Indication, 2025 to 2035
- Schizophrenia
- Bipolar Disorder
- Unipolar Depression
- Dementia-related Psychosis
- Others
- Y to o to Y Growth Trend Analysis By Disease Indication, 2020 to 2024
- Absolute $ Opportunity Analysis By Disease Indication, 2025 to 2035
- UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Drug Type
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Drug Type, 2020 to 2024
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Drug Type, 2025 to 2035
- Aripiprazole
- Risperidone
- Olanzapine
- Quetiapine
- Brexpiprazole
- Paliperidone Palmitate
- Others
- Y to o to Y Growth Trend Analysis By Drug Type, 2020 to 2024
- Absolute $ Opportunity Analysis By Drug Type, 2025 to 2035
- UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2020 to 2024
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2025 to 2035
- UK
- Market Attractiveness Analysis By Region
- UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
- By Country
- By Disease Indication
- By Drug Type
- Market Attractiveness Analysis
- By Country
- By Disease Indication
- By Drug Type
- Key Takeaways
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Disease Indication
- By Drug Type
- Competition Analysis
- Competition Deep Dive
- H. Lundbeck A/S
- Overview
- Product Portfolio
- Profitability by Market Segments (Product/Age /Sales Channel/Region)
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- Otsuka Pharmaceutical Co., Ltd.
- Janssen Pharmaceuticals Inc.
- Eli Lilly and Company
- AbbVie Inc.
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Sumitomo Pharma Co. Ltd.
- Alkermes plc
- Bristol-Myers Squibb Company
- H. Lundbeck A/S
- Competition Deep Dive
- Assumptions & Acronyms Used
- Research Methodology
List Of Table
- Table 1: UK Market Value (USD Million) Forecast by Region, 2020 to 2035
- Table 2: UK Market Value (USD Million) Forecast by Disease Indication, 2020 to 2035
- Table 3: UK Market Value (USD Million) Forecast by Drug Type, 2020 to 2035
- Table 4: UK Market Value (USD Million) Forecast by Country, 2020 to 2035
- Table 5: UK Market Value (USD Million) Forecast by Disease Indication, 2020 to 2035
- Table 6: UK Market Value (USD Million) Forecast by Drug Type, 2020 to 2035
List Of Figures
- Figure 1: UK Market Pricing Analysis
- Figure 2: UK Market Value (USD Million) Forecast 2020 to 2035
- Figure 3: UK Market Value Share and BPS Analysis by Disease Indication, 2025 and 2035
- Figure 4: UK Market Y to o to Y Growth Comparison by Disease Indication, 2025 to 2035
- Figure 5: UK Market Attractiveness Analysis by Disease Indication
- Figure 6: UK Market Value Share and BPS Analysis by Drug Type, 2025 and 2035
- Figure 7: UK Market Y to o to Y Growth Comparison by Drug Type, 2025 to 2035
- Figure 8: UK Market Attractiveness Analysis by Drug Type
- Figure 9: UK Market Value (USD Million) Share and BPS Analysis by Region, 2025 and 2035
- Figure 10: UK Market Y to o to Y Growth Comparison by Region, 2025 to 2035
- Figure 11: UK Market Attractiveness Analysis by Region
- Figure 12: UK Market Incremental Dollar Opportunity, 2025 to 2035
- Figure 13: UK Market Value Share and BPS Analysis by Country, 2025 and 2035
- Figure 14: UK Market Value Share and BPS Analysis by Disease Indication, 2025 and 2035
- Figure 15: UK Market Y to o to Y Growth Comparison by Disease Indication, 2025 to 2035
- Figure 16: UK Market Attractiveness Analysis by Disease Indication
- Figure 17: UK Market Value Share and BPS Analysis by Drug Type, 2025 and 2035
- Figure 18: UK Market Y to o to Y Growth Comparison by Drug Type, 2025 to 2035
- Figure 19: UK Market Attractiveness Analysis by Drug Type
- Figure 20: UK Market - Tier Structure Analysis
- Figure 21: UK Market - Company Share Analysis